Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date
Simulations Plus (Nasdaq: SLP), a provider of biosimulation and medical communications solutions for the biopharma industry, has scheduled its first quarter fiscal 2025 earnings release and conference call for Tuesday, January 7, 2025. The financial results will be announced after market close, followed by a management-hosted conference call at 5:00 p.m. Eastern Time.
Investors and shareholders can join the live webcast through registration or dial in using 1-877-451-6152 (domestic) or 1-201-389-0879 (international). A replay will be available on the company's investor relations website approximately one hour after the call.
Simulations Plus (Nasdaq: SLP), un fornitore di soluzioni di biosimulazione e comunicazione medica per l'industria biofarmaceutica, ha programmato il rilascio dei risultati finanziari per il primo trimestre dell'anno fiscale 2025 e una conference call per martedì 7 gennaio 2025. I risultati finanziari saranno annunciati dopo la chiusura del mercato, seguiti da una conference call ospitata dalla direzione alle 17:00, ora orientale.
Investitori e azionisti possono partecipare alla diretta attraverso la registrazione o chiamando il numero 1-877-451-6152 (nazionale) o 1-201-389-0879 (internazionale). Una registrazione sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda circa un'ora dopo la chiamata.
Simulations Plus (Nasdaq: SLP), un proveedor de soluciones de biosimulación y comunicación médica para la industria biofarmacéutica, ha programado la publicación de sus resultados financieros del primer trimestre del año fiscal 2025 y una conferencia telefónica para el martes 7 de enero de 2025. Los resultados financieros se anunciarán después del cierre del mercado, seguidos de una conferencia telefónica dirigida por la dirección a las 5:00 p.m., hora del Este.
Los inversores y accionistas pueden unirse a la transmisión en vivo a través del registro o llamando al 1-877-451-6152 (nacional) o 1-201-389-0879 (internacional). Una repetición estará disponible en el sitio web de relaciones con inversores de la empresa aproximadamente una hora después de la llamada.
Simulations Plus (Nasdaq: SLP), 생명공학 산업을 위한 바이오 시뮬레이션 및 의료 커뮤니케이션 솔루션 제공업체가 2025년 1월 7일 화요일에 2025 회계연도 첫 분기 실적 발표 및 컨퍼런스 콜을 예정했습니다. 재무 결과는 시장 마감 후 발표되며, 이어서 동부 표준시 기준 오후 5시부터 경영진이 주관하는 컨퍼런스 콜이 진행됩니다.
투자자와 주주들은 등록을 통해 실시간 웹캐스트에 참여하거나 1-877-451-6152(국내) 또는 1-201-389-0879(국제)로 전화로 참여할 수 있습니다. 콜 후 약 1시간이 지난 후 회사의 투자자 관계 웹사이트에서 다시 보기 가능합니다.
Simulations Plus (Nasdaq: SLP), un fournisseur de solutions de biosimulation et de communication médicale pour l'industrie biopharmaceutique, a prévu la publication de ses résultats financiers pour le premier trimestre de l'exercice 2025 et une conférence téléphonique pour mardi 7 janvier 2025. Les résultats financiers seront annoncés après la clôture du marché, suivis d'une conférence téléphonique animée par la direction à 17h00, heure de l'Est.
Les investisseurs et actionnaires peuvent rejoindre le webinaire en direct via une inscription ou se connecter en appelant le 1-877-451-6152 (national) ou le 1-201-389-0879 (international). Un enregistrement sera disponible sur le site web des relations investisseurs de l'entreprise environ une heure après l'appel.
Simulations Plus (Nasdaq: SLP), ein Anbieter von Biosimulations- und medizinischen Kommunikationslösungen für die Biopharmaindustrie, hat die Veröffentlichung seiner Ergebnisse für das erste Quartal des Geschäftsjahres 2025 und eine Telefonkonferenz für Dienstag, den 7. Januar 2025, geplant. Die finanziellen Ergebnisse werden nach Marktschluss bekannt gegeben, gefolgt von einer von der Geschäftsleitung geleiteten Telefonkonferenz um 17:00 Uhr Eastern Time.
Investoren und Aktionäre können über eine Registrierung an der Live-Webcast teilnehmen oder sich unter 1-877-451-6152 (inland) oder 1-201-389-0879 (international) einwählen. Eine Wiederholung wird etwa eine Stunde nach dem Call auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
Conference call to be on Tuesday, January 7, 2025, at 5 p.m. ET
Management will host a conference call that same day at 5:00 p.m. Eastern Time to discuss the results. Investment professionals and all current and prospective shareholders are invited to join the live webcast by registering here. The conference call can also be accessed by dialing 1-877-451-6152 (domestic) or 1-201-389-0879 (international) or by clicking on this Call me™ link to request a return call. The webcast can be accessed on the investor relations page of the Simulations Plus website at https://www.simulations-plus.com/investorscorporate-profile/corporate-profile/ where it will also be available for replay approximately one hour following the call.
About Simulations Plus
With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. We also deliver simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Our cutting-edge technology is licensed and utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on LinkedIn | X | YouTube.
Environmental, Social, and Governance (ESG)
We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our 2023 ESG update.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241217311617/en/
Financial Profiles
Lisa Fortuna
310-622-8251
slp@finprofiles.com
Source: Simulations Plus, Inc.
FAQ
When will Simulations Plus (SLP) report Q1 2025 earnings?
How can investors join the Simulations Plus (SLP) Q1 2025 earnings call?
What time is the Simulations Plus (SLP) Q1 2025 earnings call?
Where can I find the replay of Simulations Plus (SLP) Q1 2025 earnings call?
